Gaviscon
 

BIBLIOGRAFIA DEL SITO

Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension

(Articolo in francese)

Authors
Uzan M; Uzan S; Sureau C; Richard-Berthe C

Source:
Rev Fr Gynecol Obstet. 83(7-9):569-72, 1988 Jul-Sep.

Abstract
This open trial was conducted in 50 pregnant women, presenting during the 2nd and 3rd trimesters of their pregnancy typical symptoms of gastro-esophageal reflux (pyrosis, regurgitations, retro-sternal burning sensations, dyspepsia, epigastric burning).
The treatment with Gaviscon, suspension to drink, lasted 1 month at a dose of 2 tablespoons, 4 times/day after meals and in the evening at bedtime. After one month, all symptoms were improved, in a statistically significant fashion, regarding their frequency, intensity and duration. The efficacy is considered positive in 98 p. cent of the cases; the patient's impression is favourable in 70 p. cent of the cases.
Tolerance is excellent and the medication is satisfactorily accepted.



Gaviscon Advance il reflusso GE schema della diagnosi La malattia da reflusso gastroesofageo (MRGE) il principio attivo: l'alginato gli alginati farmacocinetica e tossicologia meccanismo d'azione efficacia antireflusso rispetto del ph gastrico la barriera antireflusso ricerche e studi richiedi informazioni
Novartis Italia